Is switching to T-DM1 still justified in HER2-negative residual breast cancer after neoadjuvant systemic therapy?
Bron
The Breast - ISSN 0960-9776-81 (2025) p. 1-2
Dynamics of SERPINA3 in response to anthracycline treatment and cardiovascular dysfunction
Bron
Cardio-Oncology - ISSN 2057-3804-11:1 (2025) p. 1-13
The effects of chemotherapy on resting energy expenditure, body composition, and cancer-related fatigue in women with breast cancer : a prospective cohort study
Bron
Cancer & metabolism - ISSN 2049-3002-11:1 (2023) p. 1-11
Validation of liquid biopsy for ESR1-mutation analysis in hormone-sensitive breast cancer : a pooled meta-analysis
Bron
Frontiers in oncology - ISSN 2234-943X-13 (2023) p. 1-12
Next-generation sequencing of circulating tumor DNA can optimize second-line treatment in RAS wild-type metastatic colorectal cancer after progression on anti-EGFR therapy : time to rethink our approach
Bron
Oncology research and treatment - ISSN 2296-5270-45:4 (2022) p. 216-220